These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26714785)

  • 1. Photoallergic Drug Eruption Caused by Certolizumab Pegol.
    Inoue A; Sawada Y; Ohmori S; Omoto D; Haruyama S; Kabashima-Kubo R; Yoshioka M; Nisio D; Nakamura M
    Acta Derm Venereol; 2016 Jun; 96(5):710-1. PubMed ID: 26714785
    [No Abstract]   [Full Text] [Related]  

  • 2. Psoriasiform skin eruption in a patient receiving certolizumab-pegol for ankylosing spondylitis: Report of a case and review of the literature.
    Babuna Kobaner G; Polat Ekinci A; Yilmaz Z; Copur S
    Dermatol Ther; 2018 Sep; 31(5):e12693. PubMed ID: 30225952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Minimal Change Disease in a Patient with Rheumatoid Arthritis Treated with Certolizumab.
    Hwang SR; Sawatsky AP
    J Rheumatol; 2019 Dec; 46(12):1647. PubMed ID: 31676702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Miller Fisher syndrome following treatment with certolizumab in a patient with rheumatoid arthritis].
    Alberola-Amores FJ; Navarro-Canto L; Gonzalez-Ferrandez JA
    Rev Neurol; 2017 Sep; 65(6):286-288. PubMed ID: 28896005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anaphylactic reaction by certolizumab in young woman with rheumatoid arthritis].
    Caballero-Requejo C; Monteagudo-González L; Urbieta-Sanz E
    Farm Hosp; 2018 May; 42(3):135-136. PubMed ID: 29730985
    [No Abstract]   [Full Text] [Related]  

  • 6. Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis.
    Koizumi H; Tokuriki A; Oyama N; Ido H; Sugiura K; Akiyama M; Hasegawa M
    J Dermatol; 2017 Jun; 44(6):723-724. PubMed ID: 27599405
    [No Abstract]   [Full Text] [Related]  

  • 7. Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases.
    Deeks ED
    BioDrugs; 2016 Dec; 30(6):607-617. PubMed ID: 27704400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Certolizumab Pegol-Induced Heart Failure.
    Lazarewicz K; Shaw S; Haque S
    J Clin Rheumatol; 2018 Jan; 24(1):55-56. PubMed ID: 29232326
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of hypocomplementemic urticarial vasculitis during certolizumab pegol treatment for rheumatoid arthritis: A case report.
    Horai Y; Ishikawa H; Iwanaga N; Izumi Y; Matsuoka Y; Miura S; Kawakami A
    J Clin Pharm Ther; 2020 Oct; 45(5):1179-1182. PubMed ID: 31990069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Certolizumab-induced lichenoid eruption in a patient with rheumatoid arthritis.
    Kunadia A; Shulman K; Sami N
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34887290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythema induratum of Bazin which occurred after tumor necrosis factor antagonist therapy.
    Baba N; Takashima W; Tokuriki A; Ameshima S; Hasegawa M
    J Dermatol; 2017 May; 44(5):e87-e88. PubMed ID: 28106269
    [No Abstract]   [Full Text] [Related]  

  • 12. Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.
    Smolen JS; van Vollenhoven R; Kavanaugh A; Strand V; Vencovsky J; Schiff M; Landewé R; Haraoui B; Arendt C; Mountian I; Carter D; van der Heijde D
    Arthritis Res Ther; 2015 Sep; 17(1):245. PubMed ID: 26353833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and effectiveness of certolizumab pegol in patients with rheumatoid arthritis: Interim analysis of post-marketing surveillance].
    Kameda H; Nishida K; Nannki T; Watanabe A; Oshima Y; Momohara S
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):196-205. PubMed ID: 28747607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice.
    Punzi L; Lapadula G; Mathieu A
    BioDrugs; 2014 Apr; 28 Suppl 1():S25-37. PubMed ID: 24687236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of certolizumab pegol: a case study in a patient with rheumatoid arthritis on maintenance hemodialysis.
    Nishimura A; Minegishi Y; Kwamura K; Ichino A; Uchiyama K
    Rheumatol Int; 2015 Sep; 35(9):1601-2. PubMed ID: 25645901
    [No Abstract]   [Full Text] [Related]  

  • 16. Psoriasiform drug eruption due to abatacept.
    Kato K; Satoh T; Nishizawa A; Yokozeki H
    Acta Derm Venereol; 2011 May; 91(3):362-3. PubMed ID: 21336469
    [No Abstract]   [Full Text] [Related]  

  • 17. Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population.
    Weinblatt ME; Fleischmann R; van Vollenhoven RF; Emery P; Huizinga TW; Cutolo M; van der Heijde D; Duncan B; Davies O; Luijtens K; Dougados M
    Arthritis Res Ther; 2015 Nov; 17():325. PubMed ID: 26568428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis.
    Hynnekleiv L; Thrane AS; Krohn J
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33012711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible relationship between certolizumab pegol and arrhythmias: report of two cases.
    Talotta R; Atzeni F; Batticciotto A; Ventura D; Sarzi-Puttini P
    Reumatismo; 2016 Sep; 68(2):104-8. PubMed ID: 27608800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylene glycol: an underrecognized compound in certolizumab pegol and Movicol that may cause anaphylaxis.
    McCabe E; Tormey V; Doran JP
    Rheumatology (Oxford); 2020 Apr; 59(4):908-910. PubMed ID: 31598712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.